Amylin is committed to assisting patients with diabetes in accessing coverage for its products. In support of this commitment, the Amylin Patient Assistance Program was established to provide temporary assistance to low income patients who do not have or do not qualify for, public or private insurance coverage for prescription drugs. To be eligible for the program, patients must meet residency, income, diagnosis and prescription drug insurance criteria. Eligible patients must reapply after six months. Please contact the Amylin Patient Assistance Program for more information and assistance in determining eligibility.

All of our products are covered by this program.

Contact Information

Amylin Patient Assistance Program
PO Box 8435
Gaithersburg, MD 20898
1-800-330-7647 (phone)

The Patient Assistance Program (PAP) enrollment instructions and application form for our products may be downloaded here:

• BYETTA® (exenatide) injection PAP Application
• SYMLIN® (pramlintide acetate) injection PAP Application

You must have the free Adobe® Reader® installed on your computer to view these PDF files. If you do not have the Adobe® Reader®, you can download it here.